Three-dimensional modeling of cytomegalovirus DNA polymerase and preliminary analysis of drug resistance

被引:19
作者
Shi, Rong
Azzi, Arezki
Gilbert, Christian
Boivin, Guy
Lin, Sheng-Xiang [1 ]
机构
[1] Ctr Hosp Univ Quebec, CHUL Hosp, Res Ctr Mol Endocrinol, Quebec City, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Ctr Hosp Univ Quebec, CHUL Hosp, Res Ctr Infect Dis, Quebec City, PQ, Canada
关键词
cytomegalvoirus; DNA polymerase; drug resistance; 3D-jury meta predictor; modeling; structure-function;
D O I
10.1002/prot.21005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytomegalovirus (CMV) is the leading cause of congenital infection and a frequent opportunistic agent in immunocompromised hosts such as transplant recipients and AIDS patients. CMV DNA polymerase, a member of the polymerase B family, is the primary target of all available antivirals (ganciclovir, cidofovir, and foscarnet) and certain variations of this enzyme could lead to drug resistance. However, understanding the drug resistance mechanisms at the atomic level is hampered by the lack of its three-dimensional (3D) structure. In the present work, 3D models of two different conformations (closed and open) for CMV DNA polymerase have been built based on the crystal structures of bacteriophage RB69 DNA polymerase (a member of the polymerase B family) by using the 3D-Jury Meta server and the program MODELLER. Most of the variations on CMV DNA polymerase pertinent to ganciclovir/cidofovir and foscarnet resistance can be explained well based on the open and closed conformation models, respectively. These results constitute a first step towards facilitating our understanding of drug resistance mechanisms for CMV and the interpretation of novel viral mutations.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 32 条
[1]   Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS [J].
Baldanti, F ;
Underwood, MR ;
Stanat, SC ;
Biron, KK ;
Chou, SW ;
Sarasini, A ;
Silini, E ;
Gerna, G .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1390-1395
[2]   Structural insights into the origins of DNA polymerase fidelity [J].
Beard, WA ;
Wilson, SH .
STRUCTURE, 2003, 11 (05) :489-496
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   COMPILATION, ALIGNMENT, AND PHYLOGENETIC-RELATIONSHIPS OF DNA-POLYMERASES [J].
BRAITHWAITE, DK ;
ITO, J .
NUCLEIC ACIDS RESEARCH, 1993, 21 (04) :787-802
[5]   Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes [J].
Brautigam, CA ;
Steitz, TA .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (01) :54-63
[6]   Multiple sequence alignment with the Clustal series of programs [J].
Chenna, R ;
Sugawara, H ;
Koike, T ;
Lopez, R ;
Gibson, TJ ;
Higgins, DG ;
Thompson, JD .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3497-3500
[7]   Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus [J].
Chou, SW ;
Lurain, NS ;
Thompson, KD ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) :32-39
[8]   Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease [J].
Chou, SW ;
Marousek, G ;
Guentzel, S ;
Follansbee, SE ;
Poscher, ME ;
Lalezari, JP ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :786-789
[9]   A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance [J].
Chou, SW ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1765-1768
[10]   A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture [J].
Cihlar, T ;
Fuller, MD ;
Mulato, AS ;
Cherrington, JM .
VIROLOGY, 1998, 248 (02) :382-393